Equities researchers at StockNews.com assumed coverage on shares of Veradigm (NASDAQ:MDRX – Get Free Report) in a research note issued on Friday. The firm set a “hold” rating on the software maker’s stock.
Veradigm Price Performance
Shares of MDRX opened at $9.45 on Friday. Veradigm has a one year low of $5.01 and a one year high of $11.80. The stock’s fifty day moving average is $10.01 and its 200-day moving average is $9.73.
Institutional Inflows and Outflows
An institutional investor recently bought a new position in Veradigm stock. Innealta Capital LLC bought a new position in Veradigm Inc. (NASDAQ:MDRX – Free Report) in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 3,974 shares of the software maker’s stock, valued at approximately $38,000.
About Veradigm
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Read More
- Five stocks we like better than Veradigm
- How to Evaluate a Stock Before BuyingÂ
- Buffett Takes the Bait; Berkshire Buys More Oxy in December
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Top 3 ETFs to Hedge Against Inflation in 2025
- Insider Buying Explained: What Investors Need to Know
- These 3 Chip Stock Kings Are Still Buys for 2025
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
